R. Akehurst

UK, USA and Canada: how do their pressure ulcer prevalence and incidence data compare?

S. Paisley, E. Kaltenthaler, R. Akehurst, 2001, Journal of wound care.

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer

S. Paisley, J. Catto, R. Akehurst, 2003, British Journal of Cancer.

A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.

A. Brennan, M. Flather, J. Karnon, 2006, International journal of cardiology.

How effective are prevention strategies in reducing the prevalence of pressure ulcers?

E. Kaltenthaler, M. Whitfield, S. Walters, 2000, Journal of wound care.

Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method

P C Lambert, Nicholas R Latimer, M J Crowther, 2017, Statistical methods in medical research.

Treatment of irritable bowel syndrome: a review of randomised controlled trials

E. Kaltenthaler, R. Akehurst, R. Akehurst, 2001, Gut.

Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom*

J. Karnon, R. Akehurst, K. Tolley, 2008, Current medical research and opinion.

Autologous transfusion, 3 years on: What is new? What has happened?

R. Akehurst, J. Allain, J. Hunter, 1999, Transfusion Medicine.